Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Mitoxantrone
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Mitoxantrone 10mg/5ml solution for infusion vials
0801020R0AAAEAE
|
Mitoxantrone | Mitoxantrone | Malignant Disease and Immunosuppression | No data available |
|
Mitoxantrone 20mg/10ml solution for infusion vials
0801020R0AAAAAA
|
Mitoxantrone | Mitoxantrone | Malignant Disease and Immunosuppression | No data available |
|
Mitoxantrone 25mg/12.5ml solution for infusion vials
0801020R0AAABAB
|
Mitoxantrone | Mitoxantrone | Malignant Disease and Immunosuppression | No data available |
|
Mitoxantrone 30mg/15ml solution for infusion vials
0801020R0AAACAC
|
Mitoxantrone | Mitoxantrone | Malignant Disease and Immunosuppression | No data available |
|
Novantrone 20mg/10ml solution for infusion vials
0801020R0BBAAAA
|
Novantrone | Mitoxantrone | Malignant Disease and Immunosuppression | No data available |
|
Novantrone 25mg/12.5ml solution for infusion vials
0801020R0BBABAB
|
Novantrone | Mitoxantrone | Malignant Disease and Immunosuppression | No data available |
|
Novantrone 30mg/15ml solution for infusion vials
0801020R0BBACAC
|
Novantrone | Mitoxantrone | Malignant Disease and Immunosuppression | No data available |
|
Onkotrone 20mg/10ml solution for infusion vials
0801020R0BCAAAA
|
Onkotrone | Mitoxantrone | Malignant Disease and Immunosuppression | No data available |
|
Onkotrone 25mg/12.5ml solution for infusion vials
0801020R0BCABAB
|
Onkotrone | Mitoxantrone | Malignant Disease and Immunosuppression | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.